$1,000 invested Merck & Co. Inc. (2021)
NYSE · MRK · reinvest dividends · adjusted close
●Result2021-01-04 — 2026-10-15
Today you would have
$2,219
+$1,219 (+121.91%)
MRKSPY (benchmark)
- Entry price
- $65.43
- Current price
- $145.19
- Shares
- 15.2840
- CAGR
- +14.80%
- Max Drawdown
- -43.44%
- vs SPY
- -2.89 pp
✦The story
A $1,000 investment in Merck & Co. at the start of 2021 grew to $2,219 by mid-2026, a return of +121.9%. The drugmaker continued to lean on its oncology franchise, led by Keytruda, throughout the period. Even so, the result trailed the S&P 500, which gained +124.8% over the same stretch.
#Related scenariosfor comparison
Other years for MRK